Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Moderna
NasdaqGS:MRNA Community
1
Narratives
written by author
1
Comments
on narratives written by author
256
Fair Values set
on narratives written by author
Create a narrative
Moderna
Popular
Undervalued
Overvalued
Moderna
WA
Analyst Price Target
Consensus Narrative from 22 Analysts
Vaccine Expansion Plans Could Shape Future Despite Market Challenges And Legal Risks
Key Takeaways Strategic product innovation in combining vaccines could enhance long-term revenue streams and international market positioning. Improved operational efficiencies and leadership focus may bolster margins and support sustainable growth strategies.
View narrative
US$62.32
FV
43.0% undervalued
intrinsic discount
-10.05%
Revenue growth p.a.
Set as Fair Value
2
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
13 days ago
author updated this narrative
Your Valuation for
MRNA
Moderna
Your Fair Value
US$
Current Price
US$35.53
53.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-5b
19b
2015
2018
2021
2024
2025
2027
2030
Revenue US$7.7b
Earnings US$1.5b
Advanced
Set as Fair Value